What is the market or research trend for Axitinib Impurity 1 (CAS: 885126-40-9)?

The market trend for Axitinib Impurity 1 (CAS: 885126-40-9) reflects the broader research interest in tyrosine kinase inhibitors. With ongoing advancements in cancer therapy and personalized medicine, there is an increasing focus on understanding and controlling impurities in drug formulations. Research trends aim to improve the purity and safety of axitinib, the parent compound, and its related impurities like Axitinib Impurity 1, to enhance therapeutic efficacy and patient safety.